Peter M. Rothwell - Concepedia

Author

Peter M. Rothwell

Also Known As

Alastair Buchan, B Colam, Ben Jansen, Cathie Sudlow, Christopher Levi, Dennis Briley, Driessen, J.J., G Pasterkamp, Hugh Markus, Hugh Watkins

1.1K

Publications

85K

Citations

150

H-Index

182

Concepts

All Affiliations

University of Oxford John Radcliffe Hospital University of Edinburgh Western General Hospital University Medical Center Utrecht

About

Peter M. Rothwell is an author at University of Oxford specializing in medicine, cardiovascular disease, and stroke.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Health Sciences	5	5	3.7K
2	Education	3	3	2.5K
3	Arts	1	1	10
4	Humanities	1	1	10
5	Law	1	1	2.4K

Peter M. Rothwell

352

Publications

48.7K

Citations

101

H-Index

Page 1

	Year	Citations
External validity of randomised controlled trials: “To whom do the results of this trial apply?” Peter M. Rothwell The Lancet Health PolicyExternal ValidityControlled TrialsClinical TrialsLaw	2005	2.4K
Analysis of shared heritability in common disorders of the brain Verneri Anttila, Brendan Bulik‐Sullivan, Hilary K. Finucane, Science Brain FunctionPsychiatric DisordersGeneticsGenetic EpidemiologyNeuropsychiatry	2018	2K
Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials Katayoun Vahedi, Jeannette Hofmeijer, Eric Jüettler, The Lancet Neurology Neuro-oncologyMedicineVascular SurgeryCerebrovascular DiseaseBrain Injury	2007	1.8K
Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension Peter M. Rothwell, Sally C. Howard, Eamon Dolan, The Lancet Blood Pressure MonitoringHypertensionVisit-to-visit VariabilityCardiovascular DiseaseAntihypertensive Therapy	2010	1.7K
Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials Peter M. Rothwell, Michelle Wilson, Carl‐Eric Elwin, The Lancet Long-term EffectCancer EpidemiologyChemoprevention StrategyMedicineRandomised Trials	2010	1.3K
Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack S. Claiborne Johnston, Peter M. Rothwell, Mai N. Nguyen‐Huynh, The Lancet Transient Ischaemic AttackThrombosisIschemic StrokeCardiovascular DiseaseMedicine	2007	1.3K
Effect of urgent treatment of transient ischaemic attack and minor stroke on early recurrent stroke (EXPRESS study): a prospective population-based sequential comparison Peter M. Rothwell, Matthew F. Giles, Arvind Chandratheva, The Lancet ThrombosisCardiovascular DiseaseIschemic StrokeMedicineEarly Recurrent Stroke	2007	1.2K
Subgroup analysis in randomised controlled trials: importance, indications, and interpretation Peter M. Rothwell The Lancet Retrospective Cohort StudyMeta-analysisHealth PolicyClinical Trial AnalysisClinical Trials	2005	914
Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial J. Michael Gaziano, Carlos Brotons, Rosa Coppolecchia, The Lancet ThrombosisHypertensionCardiovascular DiseaseMedicineModerate Risk	2018	849
Population-Based Study of Incidence and Outcome of Acute Aortic Dissection and Premorbid Risk Factor Control D. Howard, Amitava Banerjee, J.F. Fairhead, Circulation	2013	802

Page 1